NASDAQ:ASTH - Nasdaq - US03763A2078 - Common Stock - Currency: USD
28.08
+6.62 (+30.85%)
The current stock price of ASTH is 28.08 USD. In the past month the price increased by 12.77%. In the past year, price decreased by -41.39%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 10.34 | 82.91B | ||
CI | THE CIGNA GROUP | 9.79 | 73.44B | ||
LH | LABCORP HOLDINGS INC | 17.56 | 22.04B | ||
DGX | QUEST DIAGNOSTICS INC | 18.71 | 19.79B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 13.75 | 14.12B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 98.55 | 12.86B | ||
HIMS | HIMS & HERS HEALTH INC | 64.93 | 11.63B | ||
DVA | DAVITA INC | 13.36 | 9.78B | ||
GH | GUARDANT HEALTH INC | N/A | 6.72B | ||
CHE | CHEMED CORP | 19.46 | 6.37B | ||
OPCH | OPTION CARE HEALTH INC | 20.89 | 4.62B | ||
CRVL | CORVEL CORP | 47.36 | 4.43B |
Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.
ASTRANA HEALTH INC
1668 S. Garfield Avenue, 2Nd Floor
Alhambra CALIFORNIA US
Employees: 1900
Phone: 16262820288
The current stock price of ASTH is 28.08 USD. The price increased by 30.85% in the last trading session.
The exchange symbol of ASTRANA HEALTH INC is ASTH and it is listed on the Nasdaq exchange.
ASTH stock is listed on the Nasdaq exchange.
17 analysts have analysed ASTH and the average price target is 48.39 USD. This implies a price increase of 72.34% is expected in the next year compared to the current price of 28.08. Check the ASTRANA HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ASTRANA HEALTH INC (ASTH) has a market capitalization of 1.40B USD. This makes ASTH a Small Cap stock.
ASTRANA HEALTH INC (ASTH) currently has 1900 employees.
The Revenue of ASTRANA HEALTH INC (ASTH) is expected to grow by 46.79% in the next year. Check the estimates tab for more information on the ASTH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ASTH does not pay a dividend.
ASTRANA HEALTH INC (ASTH) will report earnings on 2025-11-05, after the market close.
The PE ratio for ASTRANA HEALTH INC (ASTH) is 55.06. This is based on the reported non-GAAP earnings per share of 0.51 and the current share price of 28.08 USD. Check the full fundamental report for a full analysis of the valuation metrics for ASTH.
The outstanding short interest for ASTRANA HEALTH INC (ASTH) is 3.94% of its float. Check the ownership tab for more information on the ASTH short interest.
ChartMill assigns a technical rating of 3 / 10 to ASTH. When comparing the yearly performance of all stocks, ASTH is a bad performer in the overall market: 90.53% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to ASTH. Both the profitability and the financial health of ASTH get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.51. The EPS decreased by -64.58% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.56% | ||
ROA | 2.63% | ||
ROE | 4.7% | ||
Debt/Equity | 0.54 |
ChartMill assigns a Buy % Consensus number of 84% to ASTH. The Buy consensus is the average rating of analysts ratings from 17 analysts.
For the next year, analysts expect an EPS growth of 36.88% and a revenue growth 46.79% for ASTH